Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue MMX Staining Efficacy in Colonoscopy
NCT03287219Phase 2Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- May 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of lumeblue in colorectal cancer (CRC) and colonic polyps (2 arms), sponsored by Cosmo Pharmaceuticals. Primary endpoint: Evaluation of Mucosal Staining Efficacy at 1 day. Started May 2011; status: completed.
02
Drugs
lumeblue
03
Conditions
colorectal cancer (CRC)colonic polyps
Beyond the preview
Go deeper on NCT03287219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287219.